CSPN Signs Distribution Agreement with Dara BioSciences

Article

Community Specialty Pharmacy Network, Inc (CSPN), recently announced a distribution agreement with Dara BioSciences for Soltamox (tamoxifen citrate), a nonsteroidal antiestrogen for the treatment of patients with breast cancer.

Community Specialty Pharmacy Network, Inc (CSPN), recently announced a distribution agreement with Dara BioSciences for Soltamox (tamoxifen citrate), a nonsteroidal antiestrogen for the treatment of patients with breast cancer.

Soltamox is a liquid formulation, and was made specifically for breast cancer patients who have trouble swallowing.

“This product is an important development for patients with difficulty swallowing pills or who simply prefer an oral liquid,” said Nick Calla, RPh, CSPN vice president of industry relations. “Our pharmacies will play a key role in identifying and managing the patients most in need for a liquid form of tamoxifen.”

Nick Calla and Nick Karalis, RPh, vice president of Community Specialty Pharmacy Network, are both editorial board members at Specialty Pharmacy Times. CSPN is the largest community specialty pharmacy network in the country.

For more information on Soltamox, see the product website at soltamox.com.

Related Videos
biosimilar word or concept represented by wooden letter tiles on a wooden table with glasses and a book | Image Credit: lexiconimages - stock.adobe.com
Image credit: alicja neumiler | stock.adobe.com
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Image credit: Krakenimages.com | stock.adobe.com
Human brain digital illustration. Electrical activity, flashes, and lightning on a blue background. | Image Credit: Siarhei - stock.adobe.com
Physician and kidneys
Image credit: gamjai - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.